Larry Z. Shen

Chief Executive Officer

Senior Statistical Advisor

Fellow, American Statistical Association

Dr. Shen is senior statistical advisor to numerous biopharmaceutical companies to support their drug development programs. He is President and CEO Pharmapace, Inc., a biometrics consulting and CRO company.  Dr. Shen is fellow of the American Statistical Association and recipient of the DIA award for excellence in statistics publishing. He has authored many articles on statistical methodology and their applications to drug development. 

Dr. Shen was Vice President at Amylin Pharmaceuticals heading their entire clinical development organizations and played a critical role in the development and approval of several first-in-class medicines. Following the acquisition of Amylin by Bristol-Myers-Squibb in 2013, he co-founded Pharmapace, Inc. to provide exceptional services to the biopharma industry, and served as its President and CEO. Pharmapace was later acquired by WuXi AppTec in 2019. 

Dr. Shen and his executive team recently re-acquired Pharmapace through a management buy-out. Dr. Shen obtained his Ph.D. in Statistics from the University of California at Berkeley and both BS and MS degrees in mathematics/probability theory from Beijing University in China.